{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:41:28Z","timestamp":1773074488332,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K08 DK062978"],"award-info":[{"award-number":["K08 DK062978"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1053\/j.gastro.2009.12.007","type":"journal-article","created":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T04:08:24Z","timestamp":1261454904000},"page":"1330-1337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Hip Fracture Risk in Patients With a Diagnosis of Pernicious Anemia"],"prefix":"10.1053","volume":"138","author":[{"given":"Nathan A.","family":"Merriman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Putt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2013Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2009.12.007_bib1","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0026-0495(96)90171-7","article-title":"Effects of vitamin B12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells","volume":"45","author":"Kim","year":"1996","journal-title":"Metab Clin Exp"},{"key":"10.1053\/j.gastro.2009.12.007_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM198807143190202","article-title":"Cobalamin and osteoblast-specific proteins","volume":"319","author":"Carmel","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2009.12.007_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1359\/JBMR.041018","article-title":"Low plasma vitamin B12 is associated with lower BMD: the Framingham Osteoporosis Study","volume":"20","author":"Tucker","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.gastro.2009.12.007_bib4","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1210\/jc.2007-2710","article-title":"Plasma B vitamins, homocysteine and their relation with bone loss and hip fracture in elderly men and women","volume":"93","author":"McLean","year":"2008","journal-title":"J Clin Endocrin Metab"},{"key":"10.1053\/j.gastro.2009.12.007_bib5","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jama.293.9.1082","article-title":"Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial","volume":"293","author":"Sato","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2009.12.007_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/00365529409092460","article-title":"Growth of the parathyroid glands in omeprazole-treated chickens","volume":"29","author":"Gagnemo-Persson","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2009.12.007_bib7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/00365527709181713","article-title":"The parathyroid glands in experimentally induced hypergastrinemia in the rat","volume":"12","author":"Grimelius","year":"1977","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2009.12.007_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01352010","article-title":"Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans","volume":"53","author":"Mizunashi","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"10.1053\/j.gastro.2009.12.007_bib9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3177\/jnsv.44.869","article-title":"Effect of L-lactic acid on the absorption of calcium in gastrectomized rats","volume":"44","author":"Chonan","year":"1998","journal-title":"J Nutr Sci Vitaminol"},{"key":"10.1053\/j.gastro.2009.12.007_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3177\/jnsv.44.473","article-title":"Effect of L-lactic acid on calcium absorption in rats fed omeprazole","volume":"44","author":"Chonan","year":"1998","journal-title":"J Nutr Sci Vitaminol"},{"key":"10.1053\/j.gastro.2009.12.007_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM198507113130202","article-title":"Calcium absorption and achlorhydria","volume":"313","author":"Recker","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2009.12.007_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/cs0820681","article-title":"Pernicious anaemia as a risk factor for osteoporosis","volume":"82","author":"Eastell","year":"1992","journal-title":"Clin Sci (Lond)"},{"key":"10.1053\/j.gastro.2009.12.007_bib13","first-page":"1376","article-title":"Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects","volume":"10","author":"Graziani","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.gastro.2009.12.007_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7326\/0003-4819-120-3-199402010-00006","article-title":"Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12)","volume":"120","author":"Marcuard","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2009.12.007_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2036.1996.27169000.x","article-title":"Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin","volume":"10","author":"Schenk","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2009.12.007_bib16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/07315724.1994.10718452","article-title":"Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption [see comment]","volume":"13","author":"Saltzman","year":"1994","journal-title":"J Am Coll Nutr"},{"key":"10.1053\/j.gastro.2009.12.007_bib17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.amjmed.2005.02.007","article-title":"Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial","volume":"118","author":"O'Connell","year":"2005","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2009.12.007_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1503\/cmaj.071330","article-title":"Use of proton pump inhibitors and risk of osteoporosis-related fractures [see comment]","volume":"179","author":"Targownik","year":"2008","journal-title":"CMAJ Can Med Assoc J"},{"key":"10.1053\/j.gastro.2009.12.007_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00223-006-0021-7","article-title":"Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture","volume":"79","author":"Vestergaard","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"10.1053\/j.gastro.2009.12.007_bib20","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2009.12.007_bib21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1592\/phco.28.8.951","article-title":"Proton pump inhibitor use and risk of hip fractures in patients without major risk factors","volume":"28","author":"Kaye","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.gastro.2009.12.007_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jbmr.5650070514","article-title":"Risk of fractures in patients with pernicious anemia","volume":"7","author":"Goerss","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.gastro.2009.12.007_bib23","first-page":"36","article-title":"The General Practice Research Database: quality of morbidity data","author":"Hollowell","year":"1997","journal-title":"Popul Trends"},{"key":"10.1053\/j.gastro.2009.12.007_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2125.1998.00701.x","article-title":"Use of the UK General Practice Research Database for pharmacoepidemiology","volume":"45","author":"Garcia Rodriguez","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.gastro.2009.12.007_bib25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(97)04248-7","article-title":"The UK General Practice Research Database","volume":"350","author":"Walley","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2009.12.007_bib26","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.300.6732.1092","article-title":"The Read clinical classification [see comment]","volume":"300","author":"Chisholm","year":"1990","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2009.12.007_bib27","series-title":"OXMIS Problem Codes for Primary Medical Care","author":"Perry","year":"1978"},{"key":"10.1053\/j.gastro.2009.12.007_bib28","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1001\/jama.285.14.1850","article-title":"Use of statins and risk of fractures","volume":"285","author":"van Staa","year":"2001","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2009.12.007_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","article-title":"The impact of confounder selection criteria on effect estimation [erratum appears in Am J Epidemiol 1989 Nov;130(5):1066]","volume":"129","author":"Mickey","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.gastro.2009.12.007_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pds.1115","article-title":"The relationship between time since registration and measured incidence rates in the General Practice Research Database","volume":"14","author":"Lewis","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1053\/j.gastro.2009.12.007_bib31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000064290","article-title":"Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload","volume":"91","author":"Graziani","year":"2002","journal-title":"Nephron"},{"key":"10.1053\/j.gastro.2009.12.007_bib32","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1172\/JCI111254","article-title":"An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium","volume":"73","author":"Bo-Linn","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1053\/j.gastro.2009.12.007_bib33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/07315724.1995.10718522","article-title":"Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans","volume":"14","author":"Serfaty-Lacrosniere","year":"1995","journal-title":"J Am Coll Nutr"},{"key":"10.1053\/j.gastro.2009.12.007_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1530\/eje.1.02225","article-title":"The risk of fractures in postmenopausal women with primary hyperparathyroidism","volume":"155","author":"De Geronimo","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.gastro.2009.12.007_bib35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/17453678909149275","article-title":"Increased fracture risk in hypercalcemia","volume":"60","author":"Larsson","year":"1989","journal-title":"Acta Orthop Scand"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508509021453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508509021453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T14:51:00Z","timestamp":1758034260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508509021453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0016508509021453"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2009.12.007","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hip Fracture Risk in Patients With a Diagnosis of Pernicious Anemia","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2009.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}